XML 24 R24.htm IDEA: XBRL DOCUMENT v3.20.1
Note A - Nature of Business and Summary of Significant Accounting Policies (Details Textual)
12 Months Ended
Dec. 10, 2019
$ / shares
Mar. 15, 2019
$ / shares
Dec. 17, 2018
$ / shares
Jun. 13, 2018
$ / shares
Jan. 01, 2018
USD ($)
Dec. 31, 2019
USD ($)
$ / shares
Dec. 31, 2018
USD ($)
$ / shares
Cost of Goods and Services Sold, Total           $ 5,657,353 $ 5,343,459
Accounts Receivable, Allowance for Credit Loss, Ending Balance           21,178 $ 16,895
Cash, FDIC Insured Amount           $ 1,174,000  
Common Stock, Dividends, Per Share, Cash Paid | $ / shares   $ 0.55   $ 0.50   $ 1.10 $ 1.05
Dividends, Total           $ 5,053,751 $ 4,824,035
Payments of Ordinary Dividends, Common Stock           5,049,922 4,816,239
Dividends Payable           3,829 7,796
Impairment of Long-Lived Assets Held-for-use           $ 0 0
Number of Vendors           6  
Unrecognized Tax Benefits, Ending Balance           $ 0  
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total             0
Advertising Expense           $ 28,000 13,000
Reclassification of Unrealized Gain (Loss) on Securities from AOCI to Retained Earnings            
AOCI Attributable to Parent [Member]              
Reclassification of Unrealized Gain (Loss) on Securities from AOCI to Retained Earnings             (466,025)
AOCI Attributable to Parent [Member] | Accounting Standards Update 2016-01 [Member]              
Reclassification of Unrealized Gain (Loss) on Securities from AOCI to Retained Earnings         $ (466,025)    
Distributors and Marketing Partners [Member]              
Number of Customers           2  
Renacidin [Member]              
Finite-Lived Intangible Assets, Accumulated Amortization           $ 59,296 44,472
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months           14,824  
Annual Dividend [Member]              
Common Stock, Dividends, Per Share, Cash Paid | $ / shares $ 0.55   $ 0.55        
Reclassified Certain Sales Rebates From Cost of Sales to Net Sales [Member]              
Cost of Goods and Services Sold, Total             323,836
Shipping and Handling [Member]              
Cost of Goods and Services Sold, Total           $ 76,000 $ 81,000
Customer Concentration Risk [Member] | Distributors and Marketing Partners [Member]              
Number of Customers             2
Revenue Benchmark [Member] | Product Concentration Risk [Member] | LUBRAJEL and RENACIDIN IRRIGATION [Member]              
Concentration Risk, Percentage           93.00% 94.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Lubrajel [Member]              
Concentration Risk, Percentage           67.00% 72.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Renacidin [Member]              
Concentration Risk, Percentage           26.00% 22.00%
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | Personal Care [Member] | Non-US [Member]              
Concentration Risk, Percentage           18.00% 19.00%
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | ASI [Member] | Non-US [Member]              
Concentration Risk, Percentage           75.00% 75.00%
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | ASI [Member] | CHINA              
Concentration Risk, Percentage           49.00% 55.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Distributors and Marketing Partners [Member]              
Concentration Risk, Percentage           52.00% 56.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Distributors and Marketing Partners [Member]              
Concentration Risk, Percentage           50.00% 47.00%
Cost of Goods and Service, Product and Service Benchmark [Member] | Supplier Concentration Risk [Member]              
Concentration Risk, Percentage           86.00% 80.00%